BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3506542)

  • 1. Where have dysplastic nevi led us?
    Tucker MA
    Princess Takamatsu Symp; 1987; 18():251-9. PubMed ID: 3506542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.
    Bale SJ; Dracopoli NC; Tucker MA; Clark WH; Fraser MC; Stanger BZ; Green P; Donis-Keller H; Housman DE; Greene MH
    N Engl J Med; 1989 May; 320(21):1367-72. PubMed ID: 2716782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin allotypes and familial cutaneous malignant melanoma/dysplastic nevi. A family study.
    Buchmann RB; Bale SJ; Greene MH; Pandey JP
    Exp Clin Immunogenet; 1988; 5(4):238-42. PubMed ID: 3272821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort.
    Falchi M; Spector TD; Perks U; Kato BS; Bataille V
    Hum Mol Genet; 2006 Oct; 15(20):2975-9. PubMed ID: 16928783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count.
    Gruis NA; Sandkuijl LA; Weber JL; van der Zee A; Borgstein AM; Bergman W; Frants RR
    Melanoma Res; 1993 Aug; 3(4):271-7. PubMed ID: 8219760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of cutaneous melanoma and nevi.
    Greene MH
    Mayo Clin Proc; 1997 May; 72(5):467-74. PubMed ID: 9146691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary cutaneous melanoma.
    Platz A; Ringborg U; Hansson J
    Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.
    Bale SJ; Chakravarti A; Greene MH
    Am J Hum Genet; 1986 Feb; 38(2):188-96. PubMed ID: 3456198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
    Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
    Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).
    Cannon-Albright LA; Meyer LJ; Goldgar DE; Lewis CM; McWhorter WP; Jost M; Harrison D; Anderson DE; Zone JJ; Skolnick MH
    Cancer Res; 1994 Dec; 54(23):6041-4. PubMed ID: 7954442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas.
    Hussein MR; Roggero E; Tuthill RJ; Wood GS; Sudilovsky O
    Arch Dermatol; 2003 Jun; 139(6):816-7. PubMed ID: 12810525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dysplastic nevus syndrome].
    Niebauer G; Kokoschka EM
    Wien Klin Wochenschr; 1986 Oct; 98(20):673-8. PubMed ID: 3788185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gregor Mendel and dysplastic nevi].
    Happle R
    Hautarzt; 1989 Feb; 40(2):70-6. PubMed ID: 2654075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
    Gruis NA; Van der Velden PA; Bergman W; Frants RR
    Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
    de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
    Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p.
    Kefford RF; Salmon J; Shaw HM; Donald JA; McCarthy WH
    Cancer Genet Cytogenet; 1991 Jan; 51(1):45-55. PubMed ID: 1670625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.